Drug Creation Business
The Company is a bio-venture company established based on the founder’s philosophy, “Innovative New Drugs to the World from Japan.”
We are committed to the following drug creation business for the purpose of providing patients with more beneficial drugs than conventional ones.
Fundamental Research and Elucidation of Mode of Action
- Utilizing the unique drug creation engine, we synthesizes a new material from a seed compound and repeats screening so as to demonstrate its effect in the target disease to create a candidate for a beneficial drug.
- Utilizing the drug creation engine, we explore a binding protein for a drug candidate compound and elucidate its mode of action.
- We obtain a patent on the drug candidate compound.
Licensing Out and Promotion of Development
- We license out a newly developed drug candidate compound to a partner such as a pharmaceutical manufacturer at an early clinical stage.
- Based on the partnership with the licensed-out pharmaceutical manufacturer, we share drug creation know-how to ensure that the candidate will be developed into a drug.
- We incubate in-licensed products up to clinical development.
New Drug Development Focusing on Protein Kinase Inhibitors
Our seed compounds are inhibitors of protein kinases the Company has accumulated in the past. A protein kinase is a critical enzyme in the body which has the role of intracellular signal transduction function such as differentiation and proliferation of a cell. A protein kinase inhibitor is a novelty substance that controls the function of the protein kinase. The Company creates effective drug candidate compounds by advancing development of such inhibitors that control the function of the protein kinase.